Event Title

The role of somatic symptoms in treatment choice and PTSD outcomes

Faculty Sponsor(s)

Jacob Bentley, Ph.D.

Project Type

Completed quantitative research study

Primary Department

Clinical Psychology

Description

Post-Traumatic Stress Disorder (PTSD) affects approximately 8-14% of the US population. PTSD symptoms include irritability, flashbacks, guilt, loss of sleep, and hypervigilance. Some experiences more somatic symptoms than others, including dizziness, muscle pain, gastro-intestinal issues, and headaches. These individuals often seek advice from medical practitioners which may potentially cause them to seek pharmacological treatments as opposed to other cognitive-based interventions such as Prolonged Exposure (PE). The purpose of this study is to examine how somatic symptoms influence PTSD treatment choice and outcomes. Because very few studies have examined treatment preference for PTSD patients experiencing somatic symptoms, more research is warranted.

Additional Rights Information

Copyright held by author(s).

This document is currently not available here.

Share

COinS
 
May 31st, 1:00 PM May 31st, 2:00 PM

The role of somatic symptoms in treatment choice and PTSD outcomes

Post-Traumatic Stress Disorder (PTSD) affects approximately 8-14% of the US population. PTSD symptoms include irritability, flashbacks, guilt, loss of sleep, and hypervigilance. Some experiences more somatic symptoms than others, including dizziness, muscle pain, gastro-intestinal issues, and headaches. These individuals often seek advice from medical practitioners which may potentially cause them to seek pharmacological treatments as opposed to other cognitive-based interventions such as Prolonged Exposure (PE). The purpose of this study is to examine how somatic symptoms influence PTSD treatment choice and outcomes. Because very few studies have examined treatment preference for PTSD patients experiencing somatic symptoms, more research is warranted.